Clinical and experimental dermatology · 2014
Association of the 389 C/T polymorphism of the catalase gene with susceptibility to vitiligo: a meta-analysis.
СтатьяМетаанализПоддержка исследования: вне правительства СШАОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lu L, Liu L, Ji Y, Jin H, He L
Аннотация
BACKGROUND: The 389 C/T polymorphism in the catalase gene, CAT, has been reported to be associated with the risk of vitiligo.
AIM: To evaluate the association of the CAT 389 C/T polymorphism with susceptibility to vitiligo.
METHODS: We undertook a literature search and included the relevant studies passing the selection criteria. After the relevant data were extracted from each study, we statistically analysed the strength of association between the CAT gene and vitiligo risk.
RESULTS: In total, 7 relevant studies were identified, comprising 1531 patients with vitiligo and 1608 controls. The genotype distribution in the controls of all studies complied with Hardy-Weinberg equilibrium. After pooling all studies, the results indicated that the 389 C/T polymorphisms in CAT were not associated with the risk of vitiligo in Asians and Turks; however the CT genotype might be a genetic risk factor for susceptibility to vitiligo (OR = 1.77, 95% CI 1.30-2.43, P < 0.001) and the CC genotype might decrease the risk of vitiligo (OR = 0.63, 95% CI 0.47-0.86, P < 0.01) in western Europeans.
CONCLUSIONS: The 389 C/T polymorphisms in the CAT gene may be associated with vitiligo in western Europeans. Further studies with larger sample sizes are warranted to confirm our findings.
AIM: To evaluate the association of the CAT 389 C/T polymorphism with susceptibility to vitiligo.
METHODS: We undertook a literature search and included the relevant studies passing the selection criteria. After the relevant data were extracted from each study, we statistically analysed the strength of association between the CAT gene and vitiligo risk.
RESULTS: In total, 7 relevant studies were identified, comprising 1531 patients with vitiligo and 1608 controls. The genotype distribution in the controls of all studies complied with Hardy-Weinberg equilibrium. After pooling all studies, the results indicated that the 389 C/T polymorphisms in CAT were not associated with the risk of vitiligo in Asians and Turks; however the CT genotype might be a genetic risk factor for susceptibility to vitiligo (OR = 1.77, 95% CI 1.30-2.43, P < 0.001) and the CC genotype might decrease the risk of vitiligo (OR = 0.63, 95% CI 0.47-0.86, P < 0.01) in western Europeans.
CONCLUSIONS: The 389 C/T polymorphisms in the CAT gene may be associated with vitiligo in western Europeans. Further studies with larger sample sizes are warranted to confirm our findings.